biohavenpharma.com

Biohaven Pharmaceuticals


Biohaven is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV3000-301, BHV3000-302, BHV3000-303, and others.
View Top Employees for Biohaven Pharmaceuticals
img Website biohavenpharma.com
img Industry Biotechnology
img Location New Haven, Connecticut, United States
img Employees 765
img Founded 2014
img HQ 234 Church Street
img Funding 443,700,000 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website biohavenpharma.com
img Industry Biotechnology
img Location New Haven, Connecticut, United States
img Employees 765
img Founded 2014
img LinkedIn linkedin.com/company/biohaven-pharmaceuticals-inc
img HQ 234 Church Street
img Funding 443,700,000 USD

Top Biohaven Pharmaceuticals Employees